Please consider making a tax-deductible donation to the Australian Rheumatology Association. Your support helps fund vital research, education, and advocacy for Australians living with arthritis and musculoskeletal conditions.
Updated June 2026
Secukinumab (brand name: Cosentyx®) is a medicine used to treat adults with psoriatic arthritis, a type of joint inflammation that often occurs with the skin condition called psoriasis. Secukinumab is also used to treat adults with moderate to severe chronic (long lasting) plaque psoriasis.
Secukinumab is also used to treat adults with axial spondyloarthritis, including ankylosing spondylitis, a condition which causes inflammation in the spinal joints, resulting in pain and stiffness in the spine.
Secukinumab works by blocking a protein called IL-17A that drives inflammation and can cause joint pain and stiffness in people with psoriatic arthritis and axial spondyloarthritis. This means secukinumab can reduce the inflammation and the pain and stiffness caused by too much IL-17A.
It usually takes a few weeks to notice joint swelling, pain and stiffness getting better.
If you stop or delay your secukinumab treatment, your condition may get worse. Continue your treatment unless your rheumatologist tells you to stop or unless you get side effects (see Side effects).
If you stop secukinumab for any reason, you must contact your rheumatologist. If you don’t, your treatment may stop being subsidised by Medicare.
Medicines like secukinumab are very expensive, but Medicare usually helps cover the cost if you meet certain conditions.
Secukinumab is injected just under the skin of the thigh or belly. It is best to avoid (if possible) any areas of skin affected by psoriasis. The prefilled autoinjector or syringe should be taken out of fridge 30 minutes before injecting so it can reach room temperature. Do not shake or freeze it. It can be injected by your doctor, nurse, carer, or by you. If injecting yourself, be sure to follow the detailed instructions carefully to ensure the best response. It is important to change the injection site each time.
If you miss an injection: Give the next injection as soon as you remember and continue to use it as you normally would. Do not inject a double dose to make up for a missed dose. If you have missed more than one dose or are not sure what to do, check with your doctor or pharmacist.
Secukinumab comes in a pre-filled syringe or pen which has 150mg or 300mg of medicine. Depending on your arthritis symptoms and, for some people, your psoriasis your doctor might choose one or the other strength. Either way, the usual dose is to have your injections each week for the first 5 weeks of treatment, then once every 4 weeks after that.
This medicine may be used alone or with other arthritis medicines including:
You might experience side effects with your treatment. Tell your doctor if you notice side effects that you think are caused by this medicine. Many side effects disappear when secukinumab treatment is stopped.
There are some rare but sometimes serious side effects with secukinumab including:
Infections
If you have an active infection, treatment with secukinumab will not be started until the infection is treated. Before starting secukinumab, your rheumatologist may screen you for some infections, including hepatitis B and C, HIV and tuberculosis. In most people this is done by asking you about possible past exposure to these infections and with a blood test, but some rheumatologists may choose to do a chest X-ray as well
Use with other medicines
Use with phototherapy
Vaccines
Surgery
If you need surgery for any reason, you should discuss this with your rheumatologist as some people might need to stop taking secukinumab before surgery.
Alcohol
You may drink alcohol while taking secukinumab. However, if you are also taking methotrexate, you should be cautious about how much alcohol you drink.
Use in pregnancy and when breastfeeding